6β-Acyloxy(nor)tropanes: Affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors

Journal of Medicinal Chemistry

Volumn 43, Issue 13, 2000, Pages 2514-2522

  Daly, John W ^a,b   Gupta, Tara H ^a   Padgett, William L ^a   Pei, Xue Feng ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUSCARINIC RECEPTOR; NORTROPANE DERIVATIVE; OXOTREMORINE M; QUINUCLIDINYL BENZILATE; ADENYLATE CYCLASE; DRUG DERIVATIVE; MUSCARINIC AGENT; MUSCARINIC M1 RECEPTOR; MUSCARINIC M2 RECEPTOR; MUSCARINIC M3 RECEPTOR; MUSCARINIC M4 RECEPTOR; OXOTREMORINE; TROPANE DERIVATIVE;

ARTICLE; BRAIN MEMBRANE; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; HEART MUSCLE FIBER MEMBRANE; MEMBRANE BINDING; NONHUMAN; RECEPTOR AFFINITY; ANIMAL; BINDING SITE; BRAIN CORTEX; CHEMISTRY; CHO CELL; DRUG ANTAGONISM; DRUG EFFECT; GENETIC TRANSFECTION; HAMSTER; HEART MUSCLE; HUMAN; IN VITRO STUDY; METABOLISM; RAT; SYNTHESIS;

ADENYLATE CYCLASE; ANIMALS; BINDING SITES; CEREBRAL CORTEX; CHO CELLS; CRICETINAE; HUMANS; MUSCARINIC AGONISTS; MYOCARDIUM; OXOTREMORINE; QUINUCLIDINYL BENZILATE; RATS; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M3; RECEPTOR, MUSCARINIC M4; RECEPTORS, MUSCARINIC; TRANSFECTION; TROPANES;

EID: 0034729533     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9904001     Document Type: Article

References (28)

1. Eglen, R.; Watson, N. Selective muscarinic receptor agonists and antagonists. Pharmacol. Toxicol. 1996, 78, 59-68.
2. Moltzen, E. K.; Bjornholm, B. Medicinal chemistry of muscarinic agonists: Developments since 1990. Drugs Future 1995, 20, 37-57.
3. Caulfield, M. P. Muscarinic receptors - Characterization, coupling and function. Pharmacol. Ther. 1993, 58, 319-379.
4. Freedman, S. B.; Harley, E. A.; Iversen, L. L. Relative affinities of drugs acting at cholinoceptors in displacing agonist and antagonist radioligands: The NMS/Oxo-M ratio as an index of efficacy at cortical muscarinic receptors. Br. J. Pharmacol. 1988, 93, 437-445.
5. 3H-cis-methyldioxalane binding predicts agonist or antagonist activity on muscarinic receptors. Methods Find. Exp. Clin. Pharmacol. 1988, 10, 619-621.
6. Street, L. J.; Baker, R.; Book, T.; Kneen, C. O.; MacLeod, A. M.; Merchant, K. J.; Showell, G. A.; Saunders: J.; Herbert, R. H.; Freedman, F. B.; Harley, E. A. Synthesis and biological activity of 1,2,4-oxadiazole derivatives: Highly potent and efficacious agonists for cortical muscarinic receptors. J. Med. Chem. 1990, 33, 2690-2697.
7. Arnt, J.; Lembol, H. L.; Meier, E.; Pederson, H. Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: Evidence for involvement of different muscarinic subtypes. Eur. J. Pharmacol. 1992, 218, 159-169.
8. Freedman, S. B.; Dawson, G. R.; Iversen, L. L.; Baker, R.; Hargreaves, R. J. The design of novel muscarinic partial agonists that have functional selectivity in pharmacological preparations in vitro and reduced side-effect profile in vivo. Life Sci. 1993, 52, 489-495.
9. Moltzen, E. R.; Pedersen, H.; Bøgesø, K. P.; Meier, E.; Frederickson, K.; Sánchez, C.; Lembøl, L. Bioisosteres of arecoline: 1,2,3,6-Tetrahydro-5-pyridyl-substituted and 3-piperidyl-substituted derivatives of tetrazoles and 1,2,3-triazoles. Synthesis and muscarinic activity. J. Med. Chem. 1994, 37, 4085-4099.
10. 4 muscarinic receptors: Use of NMS/OXO-M ratios to group compounds into potential agonist, partial agonist and antagonist classes. Neurochem. Res. 1995, 20, 669-674.
11. 2 receptors. J. Auton. Pharmacol. 1999, 19, 77-84.
12. Buckley, M. J.; Bonner, T. I.; Buckley, C. M.; Brann, M. R. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol. Pharmacol. 1989, 35, 469-476.
13. 2-receptors. J. Med. Chem. 1998, 41, 2047-2055.
14. Jones, J. B.; Pinder, A. R. An alkaloid of Dioscorea hispeda, Dennstedt. Part V. The degradation of dioscorinol. J. Chem. Soc. 1959, 615-619.
15. 4) in rat forebrain. Mol. Pharmacol. 1990, 38, 267-273.
16. 3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists. Mol. Pharmacol. 1987, 32, 100-108.
17. Van der Beukel, I.; Dijcks, F. A.; Vanderheyden, P.; Vauquelin, G.; Oortgiesen, M. Differential muscarinic receptor binding of acetylcholinesterase inhibitors in rat brain, human brain and chinese hamster ovary cells expressing human receptors. J. Pharmacol. Exp. Ther. 1997, 281, 1113-1119.
18. Waelbroeck, M.; Robberecht, P.; Chatelain, P.; Christophe, J. Rat cardiac muscarinic receptors. 1. Effects of guanine nucleotides on high- and low-affinity binding sites. Mol. Pharmacol. 1982, 21, 581-588.
19. 35S]GTPγS to brain membranes. Cell. Mol. Neurobiol. 1995, 15, 465-493.
20. Van Giersbergen, P. L. M.; Leppik, R. Modulation of agonist binding by guanine nucleotides in CHO cells expressing muscarinic m1-m5 receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 1999, 352, 166-172.
21. Waelbroeck, M.; Camus, J.; Winand, J.; Christophe, J. Different antagonist binding properties of pancreatic and cardiac muscarinic receptors. Life Sci. 1987, 41, 2235-2240.
22. Moriya, H.; Takagi, Y.; Nakanishi, T.; Hayashi, M.; Tani, T.; Hirotsu, I. Affinity profiles of various muscarinic antagonists for cloned human muscarinic acetylcholine receptor (MACHR) subtypes and MACHRS in rat heart and submandibular gland. Life Sci. 1999, 64, 2351-2358.
23. Aronstam, R. S.; Ryan, U. S.; Catravas, J. D. Muscarinic binding sites on bovine pulmonary arterial endothetial cells in culture. Pharmacology 1992, 44, 324-333.
24. Birdsall, N. J. M.; Burgen, A. S. V.; Hulme, E. C. The binding of agonists to brain muscarinic receptors. Mol. Pharmacol. 1978, 14, 723-736.
25. Hulme, E. C.; Birdsall, N. J. M.; Burgen, A. S. V.; Mehta, P. The binding of antagonists to brain muscarinic receptors. Mol. Pharmacol. 1978, 14, 737-750.
26. Burgisser, E.; De Lean, A.; Lefkowitz, R. J. Reciprocal modulation of agonist and antagonist binding to muscarinic cholinergic receptor by guanine nucleotide. Proc. Natl. Acad. Sci. U.S.A. 1982, 79, 1732-1736.
27. Liu, J.; Blin, N.; Conklin, B. R.; Wess, J. Molecular mechanisms involved in muscarinic acetylcholine receptor-mediated G protein activation studied by insertion mutagenesis. J. Biol. Chem. 1996, 271, 6172-6178.
28. Salomon, Y.; Londos, C.; Rodbell, M. A highly sensitive adenylate cyclase assay. Anal. Chem. 1974, 58, 541-548.